SCHEMBL28295087

SCHEMBL28295087

CC(C)(C)c1cc([N+](=O)[O-])c(OC(=O)O)c(C(C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 2/20 0.42
NPC1 O15118 2/20 0.42
MAPK1 P28482 2/20 0.42
RAB9A P51151 2/20 0.42
GLA P06280 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
MEN1 O00255 1/20 0.41
GALR3 O60755 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GPR35 Q9HC97 1/20 0.41
TPMT P51580 1/20 0.38
NPSR1 Q6W5P4 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28075474 0.90 ALDH1A1 (0.46) ALDH1A1TDP1TSHRHTTNPC1
SCHEMBL25874904 0.88 ALDH1A1 (0.44) ALDH1A1TDP1TSHRHTTNPC1
SCHEMBL29551918 0.86 ALDH1A1 (0.46) ALDH1A1TDP1TSHRHTTNPC1
SCHEMBL399194 0.86 ALDH1A1 (0.46) ALDH1A1TDP1TSHRHTTNPC1
SCHEMBL10985384 0.85 KMT2A (0.57) ALDH1A1TDP1TSHRHTTMAPK1
SCHEMBL10977680 0.85 KMT2A (0.57) ALDH1A1TDP1TSHRHTTMAPK1
SCHEMBL13376134 0.81 ALDH1A1 (0.60) ALDH1A1TDP1TSHRHTTNPC1
SCHEMBL397532 0.78 GPR35 (0.62) ALDH1A1TDP1TSHRHTTNPC1
SCHEMBL10977678 0.75 KMT2A (0.54) ALDH1A1TDP1TSHRHTTMAPK1
SCHEMBL8347607 0.75 CD69 (0.43) ALDH1A1TDP1TSHRHTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119033710-A Pharmaceutical composition for treating cystic fibrosis 弗特克斯药品有限公司 2024-11-29 CN disclosed
CN-111818918-B Pharmaceutical composition for treating cystic fibrosis 弗特克斯药品有限公司 2024-08-23 CN disclosed
CN-109803962-B Modulators of cystic fibrosis transmembrane conductance regulator proteins, and pharmaceutical compositions 弗特克斯药品有限公司 2022-04-29 CN disclosed
CN-109803962-A Modulators of cystic fibrosis transmembrane conductance regulator proteins, pharmaceutical compositions, methods of treatment, and methods for making the modulators 弗特克斯药品有限公司 2019-05-24 CN disclosed